Login / Signup

Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009-2018.

Nahid MoradiSifat SharminCharles MalpasSerkan OzakbasVahid ShaygannejadMurat TerziCavit BozBassem YamoutRecai TurkogluRana KarabudakSherif HamdyAysun SoysalAyşe AltıntaşJihad InshasiTalal Al-HarbiRaed AlroughaniTomas Kalinciknull null
Published in: CNS drugs (2021)
Patients in the Middle East enrolled in a large multinational registry are representative of the general MS population. The spectrum of therapies used in the individual countries, however, is highly variable. Further studies that include rural and non-academic practices are needed to enhance our understanding of the MS cohorts in the Middle East.
Keyphrases
  • multiple sclerosis
  • end stage renal disease
  • mass spectrometry
  • ms ms
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • healthcare
  • primary care
  • peritoneal dialysis
  • white matter
  • cross sectional